Surgery for Aortic Prosthetic Valve Endocarditis in the Transcatheter Era

Medientyp: E-Artikel

Titel: Surgery for Aortic Prosthetic Valve Endocarditis in the Transcatheter Era

Beteiligte: Saha, Shekhar [Verfasser:in]; Ali, Ahmad [Verfasser:in]; Schnackenburg, Philip [Verfasser:in]; Horke, Konstanze Maria [Verfasser:in]; Oberbach, Andreas [Verfasser:in]; Schlichting, Nadine [Verfasser:in]; Sadoni, Sebastian [Verfasser:in]; Rizas, Konstantinos [Verfasser:in]; Braun, Daniel [Verfasser:in]; Lühr, Maximilian [Verfasser:in]; Bagaev, Erik [Verfasser:in]; Hagl, Christian [Verfasser:in]; Joskowiak, Dominik [Verfasser:in]

Erschienen: Basel: MDPI, [2023]

Sprache: Englisch

Schlagwörter: prosthetic valve endocarditis ; transcatheter aortic valve implantation ; infective endocarditis

Entstehung:

Anmerkungen:

Beschreibung: Objectives: As surgical experience with infective endocarditis following transcatheter aorticvalve replacement is scarce, this study compared the perioperative and short-term outcomes of patientssuffering from endocarditis following surgical aortic valve replacement and transcatheter aorticvalve replacement. Methods: Between January 2013 and December 2020, 468 consecutive patientswere admitted to our center for surgery for IE. Among them, 98 were operated on for endocarditisfollowing surgical aortic valve replacement and 22 for endocarditis following transcatheter aorticvalve replacement. Results: The median EuroSCORE II (52.1 (40.6–62.0) v/s 45.4 (32.6–58.1), p = 0.207)and STS-PROM (1.8 (1.6–2.1) v/s 1.9 (1.4–2.2), p = 0.622) were comparable. Endocarditis followingtranscatheter aortic valve replacement accounted for 13.7% of the aortic prosthetic valve endocarditisbetween 2013 and 2015; this increased to 26.9% in the years 2019 and 2020.Concomitant procedureswere performed in 35 patients (29.2%). The operative mortality was 26.5% in the endocarditis followingsurgical aortic valve replacement group and 9.1% in the endocarditis following transcatheteraortic valve replacement group (p = 0.098). Upon follow-up, survival at 6 months was found to be98% in the group with endocarditis following surgical aortic valve replacement and 89% in the groupwith endocarditis following transcatheter aortic valve replacement (p = 0.081). Conclusions: Patientssuffering from endocarditis following surgical aortic valve replacement and transcatheter aortic valvereplacement present with comparable risk profiles and can be surgically treated with comparableresults. Surgery as a curative option should not be rejected even in this intermediate-risk cohort

Zugangsstatus: Freier Zugang

Rechte-/Nutzungshinweise: Namensnennung (CC BY)

Nur in Feld suchen:

Zuletzt gesuchte Begriffe: